🌅 Today's Morning Call
|
S&P Futures
7,196.00
▼ -7.00 (-0.10%)
|
Nasdaq Futures
27,481.00
▼ -46.50 (-0.17%)
|
Dow Futures
49,332.00
▼ -16.00 (-0.03%)
|
|
10Y Treasury
4.31%
▼ -0.01%
|
US Dollar
98.33
▼ -0.10 (-0.10%)
|
Bitcoin
$77,779
▼ -$886 (-1.13%)
|
Data as of 8:07 AM ET
Good morning! It is Monday, April 27, 2026, and the pre-market is opening the week with a mild shrug lower across the board. Futures are barely in the red, which means the real action this morning is coming from individual names rather than the broader tape. From airline merger talks to a landmark gene-editing trial win, there is plenty to chew on before the bell rings. Here is your morning rundown.
👀 What to Watch Today
The earnings calendar is front and center this week, but today the spotlight falls on consumer sentiment data and any Fed speaker commentary that could nudge the 10-year yield off its current perch at 4.31%. Traders will be watching whether softening Treasury yields can provide a floor for equities after last week's volatility.Domino's Pizza (DPZ) already reported a same-store sales miss for Q1 before the session kicks off, and the read-through matters. If Americans are pulling back on a $15 pizza order, the broader discretionary sector deserves a second look heading into the trading day.
On the deal front, Eli Lilly's (LLY) announced acquisition of Ajax Therapeutics for up to 2.3 billion dollars and Ligand Pharmaceuticals' (LGND) 740 million dollar pickup of Xoma will both be closely watched for any analyst reaction and price target revisions as the session gets underway.
Your Phone Is Smarter Than Your Inbox
Markets move fast. By the time you open your email, the opportunity is already gone. That's why we built Financial Edge Daily SMS — market insights, stocks on our radar, and plays worth considering, delivered straight to your phone. No fluff, no noise. No charge.
Text Me the Alerts🌏 Overnight Recap
Overnight in Asia, SK Hynix (HXSCL) stole the show with shares surging more than 7 percent to a record high, riding the momentum from Intel's strong earnings results that rekindled optimism around AI-driven chip demand. Samsung posted a more modest 2.5 percent gain, but the direction was clear: memory chip names are waking up.Google (GOOG, GOOGL) also made headlines overnight after South Korea's presidential office confirmed a deal to establish a new AI campus in Seoul. The initiative will link Google with local engineers and startups, reinforcing the company's commitment to expanding its AI infrastructure footprint well beyond U.S. borders.
In Europe, markets opened cautiously with the Dollar Index (DXY) ticking down to 98.33, which is quietly supportive for multinational earnings. Bitcoin slipped 1.13 percent to sit at 77,779, reflecting a mild risk-off tone that mirrors the modest futures pullback heading into New York's open.
Sponsored Content
How To Profit From Starlink’s $180 Billion IPO Jackpot?
Have you heard the big news? Elon Musk’s company Starlink is preparing to announce their IPO! According to Quartz, “Elon Musk’s Starlink IPO may lift off any day now”. And for the first time ever,...
📊 Pre-Market Movers
Intellia Therapeutics (NTLA) is the biotech name to watch this morning after announcing a successful Phase 3 trial for its CRISPR-based treatment targeting a rare swelling disorder. Gene-editing breakthroughs of this scale rarely go unnoticed by the market, and pre-market volume should reflect that. Peer names in the space could see spillover interest.Medtronic (MDT) is holding steady after confirming over the weekend that last week's cyberattack had zero operational impact on its products or patient care capacity. That is about as clean a damage-control statement as you can get, and MDT should trade relatively calm as a result.
On the deal side, Ligand Pharmaceuticals (LGND) is in focus after its 740 million dollar acquisition of Xoma, a fellow royalty-model pharma investor. Meanwhile, Domino's (DPZ) is facing pre-market pressure after that Q1 same-store sales miss, a reminder that the consumer spending squeeze is showing up in some unexpected places.
🔍 Today's Watchlist
- UAL and AAL: United Airlines CEO confirms merger outreach to American Airlines. Any further confirmation or regulatory commentary could spark big moves in both names.
- NTLA: Intellia Therapeutics reports a Phase 3 win for its CRISPR-based therapy. Watch for analyst upgrades and sector sympathy plays in gene-editing names.
- LLY: Eli Lilly's 2.3 billion dollar Ajax Therapeutics deal signals continued appetite for oncology assets. Price target revisions expected throughout the session.
- 10-Year Treasury at 4.31%: Yields nudging lower could provide modest support for growth stocks. Any shift higher would pressure high-multiple tech names.
- DPZ: Domino's same-store sales miss is a consumer spending warning flag. Watch fast casual and discretionary peers for sympathy weakness early in the session.
Sponsored Content
The Sub-$1 Pre-IPO AI Stock That Could Make People "Superhuman"
When Google, Meta, and Microsoft all back the same startup, that's not a coincidence. Immersed is changing how people work in AR/VR — 1.5M users, $7M in revenue, and a Visor headset that beats Apple...
🎯 The Morning Playbook
Today is shaping up to be a stock-picker's session rather than a macro-driven tape. The headline futures dip is minimal, which means the gains and losses will be made in individual names tied to earnings, deals, and trial results. Focus on the catalysts, not the index moves.The airline merger story between UAL and AAL is worth keeping on a short leash. Merger talks in heavily regulated industries can move fast or stall equally fast, and the volatility in both names could be meaningful if any new details surface during the trading day.
Zoom out for a moment and the bigger picture looks constructive. Yields are easing slightly, deal activity is picking up, and a major gene-editing therapy just cleared a Phase 3 hurdle. Markets reward progress, and there is genuine progress showing up across sectors today. Stay selective and stay curious.